RESEARCH &
DEVELOPMENT
Since its inception, Ichor has firmly believed that Research and Development (R&D) is a continuous and essential part of our vision. Our well-established and seamlessly integrated analytical and advanced Research & Development infrastructure supports all stages, from preclinical studies to lab-scale research, pilot-scale development, and full tech transfer to commercial manufacturing, ensuring reproducibility and consistency at every level. We believe that great medicines start with great science.
Aligned with our mission, the R&D team relentlessly focuses on continually improving existing processes and developing new, cutting-edge methods to produce high-quality plasma-derived therapeutics using the latest separation and purification techniques for plasma proteins.
All plasma derivatives manufactured at Ichor adhere to the most rigorous international standards of quality, efficacy, and safety, reflecting our commitment to excellence and innovation in plasma therapeutics.
Infrastructure
Our integrated R&D facility supports:
- Preclinical studies
- Lab-scale research
- Pilot-scale development
- Tech transfer to commercial manufacturing
Process Excellence
Unlike traditional and Second World War period developed ethanol-based Cohn fractionation methods, Ichor employs a modern, end-to-end chromatography-based fractionation process, which offers superior protein purity, and consistency.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
